Literature DB >> 16260113

Application of boron-entrapped stealth liposomes to inhibition of growth of tumour cells in the in vivo boron neutron-capture therapy model.

H Yanagie1, K Maruyama, T Takizawa, O Ishida, K Ogura, T Matsumoto, Y Sakurai, T Kobayashi, A Shinohara, J Rant, J Skvarc, R Ilic, G Kuhne, M Chiba, Y Furuya, H Sugiyama, T Hisa, K Ono, H Kobayashi, M Eriguchi.   

Abstract

Tumour cell destruction in boron neutron-capture therapy (BNCT) is due to the nuclear reaction between (10)B and thermal neutrons. It is necessary for effective BNCT therapy to accumulate (10)B atoms in the tumour cells. The delivery system consisted of polyethylene-glycol (PEG) binding liposomes (DPPC/cholesterol/DSPC-PEG2000) with an entrapped (10)B-compound and we evaluated the cytotoxic effects of intravenously injected (10)B-PEG-liposomes on human pancreatic carcinoma xenografts in nude mice with thermal neutron irradiation. After thermal neutron irradiation of mice injected with (10)B-PEG-liposomes, growth of AsPC-1 tumours was suppressed relative to controls. Injection of (10)B-PEG-liposomes caused the greatest tumour suppression with thermal neutron irradiation in vivo. These results suggest that intravenous injection of (10)B-PEG-liposomes can increase the retention of (10)B atoms by tumour cells, causing suppression of tumour growth in vivo, after thermal neutron irradiation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16260113     DOI: 10.1016/j.biopha.2005.05.011

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  6 in total

1.  Selective boron delivery by intra-arterial injection of BSH-WOW emulsion in hepatic cancer model for neutron capture therapy.

Authors:  Hironobu Yanagie; Novriana Dewi; Syushi Higashi; Ichiro Ikushima; Koji Seguchi; Ryoji Mizumachi; Yuji Murata; Yasuyuki Morishita; Atsuko Shinohara; Shoji Mikado; Nakahiro Yasuda; Mitsuteru Fujihara; Yuriko Sakurai; Kikue Mouri; Masashi Yanagawa; Tomoya Iizuka; Minoru Suzuki; Yoshinori Sakurai; Shin-Ichiro Masunaga; Hiroki Tanaka; Takehisa Matsukawa; Kazuhito Yokoyama; Takashi Fujino; Koichi Ogura; Yasumasa Nonaka; Hirotaka Sugiyama; Tetsuya Kajiyama; Sho Yui; Ryohei Nishimura; Koji Ono; Sinichi Takamoto; Jun Nakajima; Minoru Ono; Masazumi Eriguchi; Kenichiro Hasumi; Hiroyuki Takahashi
Journal:  Br J Radiol       Date:  2017-05-25       Impact factor: 3.039

Review 2.  Nanotargeted radionuclides for cancer nuclear imaging and internal radiotherapy.

Authors:  Gann Ting; Chih-Hsien Chang; Hsin-Ell Wang; Te-Wei Lee
Journal:  J Biomed Biotechnol       Date:  2010-08-03

Review 3.  Preparing (Metalla)carboranes for Nanomedicine.

Authors:  Marta Gozzi; Benedikt Schwarze; Evamarie Hey-Hawkins
Journal:  ChemMedChem       Date:  2021-03-19       Impact factor: 3.466

4.  Suppression of Tumor Growth in a Rabbit Hepatic Cancer Model by Boron Neutron Capture Therapy With Liposomal Boron Delivery Systems.

Authors:  Hironobu Yanagie; Masashi Yanagawa; Yasuyuki Morishita; Atsuko Shinohara; Novriana Dewi; Yasumasa Nonaka; Yoshitaka Furuya; Ryouji Mizumachi; Yuuji Murata; Hiroyuki Nakamura; Minoru Suzuki; Yoshinori Sakurai; Hiroki Tanaka; Shinichiro Masunaga; Koji Ono; Takumichi Sugihara; Masayuki Nashimoto; Haruo Yamauchi; Minoru Ono; Jun Nakajima; Hiroyuki Takahashi
Journal:  In Vivo       Date:  2021 Nov-Dec       Impact factor: 2.155

5.  Gold Nanoparticles as Boron Carriers for Boron Neutron Capture Therapy: Synthesis, Radiolabelling and In vivo Evaluation.

Authors:  Krishna R Pulagam; Kiran B Gona; Vanessa Gómez-Vallejo; Jan Meijer; Carolin Zilberfain; Irina Estrela-Lopis; Zuriñe Baz; Unai Cossío; Jordi Llop
Journal:  Molecules       Date:  2019-10-07       Impact factor: 4.411

6.  Antitumour effect of polyoxomolybdates: induction of apoptotic cell death and autophagy in in vitro and in vivo models.

Authors:  A Ogata; H Yanagie; E Ishikawa; Y Morishita; S Mitsui; A Yamashita; K Hasumi; S Takamoto; T Yamase; M Eriguchi
Journal:  Br J Cancer       Date:  2007-12-18       Impact factor: 7.640

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.